Cargando…
Prevalence of the Brazilian TP53 Founder c.1010G>A (p.Arg337His) in Lung Adenocarcinoma: Is Genotyping Warranted in All Brazilian Patients?
In Southern and Southeastern Brazil, there is a germline pathogenic variant with incomplete penetrance located in the oligomerization domain of TP53, c.1010G>A (p.Arg337His). Due to a founder effect, the variant is present in 0.3% of the general population of the region. Recently, this variant wa...
Autores principales: | Vieira, Igor Araujo, Andreis, Tiago Finger, Fernandes, Bruna Vieira, Achatz, Maria Isabel, Macedo, Gabriel S., Schramek, Daniel, Ashton-Prolla, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885268/ https://www.ncbi.nlm.nih.gov/pubmed/33603772 http://dx.doi.org/10.3389/fgene.2021.606537 |
Ejemplares similares
-
Ancestry of the Brazilian TP53 c.1010G>A (p.Arg337His, R337H) Founder Mutation: Clues from Haplotyping of Short Tandem Repeats on Chromosome 17p
por: Paskulin, Diego Davila, et al.
Publicado: (2015) -
TP53 p.Arg337His geographic distribution correlates with adrenocortical tumor occurrence
por: Seidinger, Ana L., et al.
Publicado: (2020) -
TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients
por: Hahn, Eriza Cristina, et al.
Publicado: (2018) -
The Brazilian TP53 mutation (R337H) and sarcomas
por: Volc, Sahlua Miguel, et al.
Publicado: (2020) -
Comparison of multiple genotyping methods for the identification of the
cancer predisposing founder mutation p.R337H inTP53
por: Fitarelli-Kiehl, Mariana, et al.
Publicado: (2016)